Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $227.07 million. The enterprise value is $294.39 million.
| Market Cap | 227.07M |
| Enterprise Value | 294.39M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 76.20 million shares outstanding. The number of shares has increased by 42.95% in one year.
| Current Share Class | 76.20M |
| Shares Outstanding | 76.20M |
| Shares Change (YoY) | +42.95% |
| Shares Change (QoQ) | +5.09% |
| Owned by Insiders (%) | 19.88% |
| Owned by Institutions (%) | 24.79% |
| Float | 37.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.45 |
| Forward PS | 1.33 |
| PB Ratio | 12.34 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 4.00.
| Current Ratio | 1.88 |
| Quick Ratio | 1.25 |
| Debt / Equity | 4.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.52 |
Financial Efficiency
Return on equity (ROE) is -116.10% and return on invested capital (ROIC) is -12.74%.
| Return on Equity (ROE) | -116.10% |
| Return on Assets (ROA) | -10.55% |
| Return on Invested Capital (ROIC) | -12.74% |
| Return on Capital Employed (ROCE) | -21.76% |
| Weighted Average Cost of Capital (WACC) | 9.76% |
| Revenue Per Employee | $235,708 |
| Profits Per Employee | -$46,249 |
| Employee Count | 658 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 15.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.35% in the last 52 weeks. The beta is 1.12, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -12.35% |
| 50-Day Moving Average | 2.01 |
| 200-Day Moving Average | 1.66 |
| Relative Strength Index (RSI) | 62.12 |
| Average Volume (20 Days) | 3,038,628 |
Short Selling Information
The latest short interest is 9.33 million, so 12.24% of the outstanding shares have been sold short.
| Short Interest | 9.33M |
| Short Previous Month | 9.37M |
| Short % of Shares Out | 12.24% |
| Short % of Float | 25.11% |
| Short Ratio (days to cover) | 4.71 |
Income Statement
In the last 12 months, Neuronetics had revenue of $155.10 million and -$30.43 million in losses. Loss per share was -$0.44.
| Revenue | 155.10M |
| Gross Profit | 76.59M |
| Operating Income | -22.46M |
| Pretax Income | -30.85M |
| Net Income | -30.43M |
| EBITDA | -19.26M |
| EBIT | -22.46M |
| Loss Per Share | -$0.44 |
Balance Sheet
The company has $19.20 million in cash and $86.52 million in debt, with a net cash position of -$67.33 million or -$0.88 per share.
| Cash & Cash Equivalents | 19.20M |
| Total Debt | 86.52M |
| Net Cash | -67.33M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | 21.64M |
| Book Value Per Share | 0.23 |
| Working Capital | 24.92M |
Cash Flow
In the last 12 months, operating cash flow was -$10.31 million and capital expenditures -$944,000, giving a free cash flow of -$11.25 million.
| Operating Cash Flow | -10.31M |
| Capital Expenditures | -944,000 |
| Depreciation & Amortization | 3.20M |
| Net Borrowing | 4.79M |
| Free Cash Flow | -11.25M |
| FCF Per Share | -$0.15 |
Margins
Gross margin is 49.38%, with operating and profit margins of -14.48% and -19.62%.
| Gross Margin | 49.38% |
| Operating Margin | -14.48% |
| Pretax Margin | -19.89% |
| Profit Margin | -19.62% |
| EBITDA Margin | -12.42% |
| EBIT Margin | -14.48% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.95% |
| Shareholder Yield | -42.95% |
| Earnings Yield | -13.56% |
| FCF Yield | -5.01% |
Analyst Forecast
The average price target for Neuronetics is $6.00, which is 101.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 101.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 8.57% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.39 |
| Piotroski F-Score | 2 |